Cell Science & Technology Institute is Biotechnology in Japan that focus on regenerative transplantation business. Founded in 2001. They cover business area such as developer, manufacturer, serum-free fluid medium, human cell, well-being, test research and antibody medicine production, cancer immune cell therapy, regenerative transplantation medical care.
2001
( 23 years old in 2024 )
Regenerative Transplantation
-
Nishi-en Garden
1-chome, Miyagi ken
Aoba-ku, 982-0262
Japan
Private
developermanufacturerserum-free fluid mediumhuman cellwell-beingtest research and antibody medicine productioncancer immune cell therapyregenerative transplantation medical care
* We use standard office opening hours in near Cell Science & Technology Institute's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cell Science & Technology Institute is Biotechnology business from Japan that founded in 2001 (23 years old in 2024), Cell Science & Technology Institute business is focusing on Regenerative Transplantation.
Cell Science & Technology Institute headquarter office and corporate office address is located in Nishi-en Garden 1-chome, Miyagi ken Aoba-ku, 982-0262 Japan.
Cell Science & Technology Institute was founded in Japan.
In 2024, Cell Science & Technology Institute is currently focus on regenerative transplantation sector.
Above is snippet of Google Trends for "regenerative transplantation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cell Science & Technology Institute, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
